Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk

T. Lecompte, D. Wahl*, C. Perret - Guillaume, H.C. Hemker, P. Lacolley, V. Regnault

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Web of Science)
247 Downloads (Pure)


Interference of antiphospholipid antibodies (aPL) with coagulation was investigated in 40 aPL-patients (24 with thrombosis) using thrombography. Impairment of the activated protein C anticoagulant pathway was partially offset by the genuine anticoagulant effect. The net result, a procoagulant phenotype, was associated with a 7-fold increased risk of thrombosis in aPL-patients.
Original languageEnglish
Pages (from-to)714-5
JournalHaematologica-the Hematology Journal
Publication statusPublished - 1 Jan 2007

Cite this